Avalo Therapeutics Statistics

Total Valuation

AVTX has a market cap or net worth of $12.68 million. The enterprise value is -$97.50 million.

Market Cap	12.68M
Enterprise Value	-97.50M

Important Dates

The next estimated earnings date is Thursday, August 1, 2024, before market open.

Earnings Date	Aug 1, 2024
Ex-Dividend Date	n/a

Share Statistics

AVTX has 1.03 million shares outstanding. The number of shares has increased by 1,780.17% in one year.

Shares Outstanding	1.03M
Shares Change (YoY)	+1,780.17%
Shares Change (QoQ)	+29.01%
Owned by Insiders (%)	5.74%
Owned by Institutions (%)	25.39%
Float	782,847

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.74
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.52

Current Ratio	0.52
Quick Ratio	0.51
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-56.89

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-288.30%
Return on Capital (ROIC)	n/a
Revenue Per Employee	$76,316
Profits Per Employee	-$7.52M
Employee Count	19
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

In the past 12 months, AVTX has paid $13,000 in taxes.

Income Tax	13,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -85.45% in the last 52 weeks. The beta is 1.14, so AVTX's price volatility has been higher than the market average.

Beta (5Y)	1.14
52-Week Price Change	-85.45%
50-Day Moving Average	12.34
200-Day Moving Average	14.70
Relative Strength Index (RSI)	50.39
Average Volume (20 Days)	16,165

Short Selling Information

The latest short interest is 75,359, so 7.29% of the outstanding shares have been sold short.

Short Interest	75,359
Short Previous Month	81,791
Short % of Shares Out	7.29%
Short % of Float	9.63%
Short Ratio (days to cover)	3.19

Income Statement

In the last 12 months, AVTX had revenue of $1.45 million and -$142.88 million in losses. Loss per share was -$192.60.

Revenue	1.45M
Gross Profit	796,000
Operating Income	-51.33M
Pretax Income	-142.87M
Net Income	-142.88M
EBITDA	-140.24M
EBIT	-140.40M
Loss Per Share	-$192.60

Full Income Statement

Balance Sheet

The company has $110.18 million in cash and no debt, giving a net cash position of $110.18 million or $106.54 per share.

Cash & Cash Equivalents	110.18M
Total Debt	n/a
Net Cash	110.18M
Net Cash Per Share	$106.54
Equity (Book Value)	-112.54M
Book Value Per Share	-108.83
Working Capital	-104.49M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-26.83M
Capital Expenditures	n/a
Free Cash Flow	-26.83M
FCF Per Share	-$25.95

Full Cash Flow Statement

Margins

Gross margin is 54.90%, with operating and profit margins of -3,539.66% and -9,853.72%.

Gross Margin	54.90%
Operating Margin	-3,539.66%
Pretax Margin	-9,852.83%
Profit Margin	-9,853.72%
EBITDA Margin	-9,671.66%
EBIT Margin	-9,682.62%
FCF Margin	-1,850.34%

Dividends & Yields

AVTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,780.17%
Shareholder Yield	-1,780.17%
Earnings Yield	-1,126.95%
FCF Yield	-211.62%

Analyst Forecast

The average price target for AVTX is $107.50, which is 776.84% higher than the current price. The consensus rating is "Buy".

Price Target	$107.50
Price Target Difference	776.84%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on December 29, 2023. It was a reverse split with a ratio of 1:240.

Last Split Date	Dec 29, 2023
Split Type	Reverse
Split Ratio	1:240

Scores

AVTX has an Altman Z-Score of -9.88 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-9.88
Piotroski F-Score	1